Dupont Jakob has filed 22 insider transactions across 3 companies since March 2023.
Most recent transaction: a grant/award of 45867 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | D | Director Stock Option (Right to Buy) | 1100 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Director Stock Option (Right to Buy) | 1100 | $0.00 | 1,100.0000 | 1,919,441 | 9999.99% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | D | Director Stock Option (Right to Buy) | 1000 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.05% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Director Stock Option (Right to Buy) | 1000 | $0.00 | 1,000.0000 | 1,919,441 | 9999.99% | 0.05% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | D | Director Stock Option (Right to Buy) | 849 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.04% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Director Stock Option (Right to Buy) | 849 | $0.00 | 849.0000 | 1,919,441 | 9999.99% | 0.04% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | D | Director Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.13% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Director Stock Option (Right to Buy) | 2500 | $0.00 | 2,500.0000 | 1,919,441 | 9999.99% | 0.13% |
| May 27, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 1100 | $0.00 | 1,100.0000 | 38,339,697 | 9999.99% | 0.00% |
| May 1, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 38,339,697 | 9999.99% | 0.05% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| Sept. 3, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 16984 | $0.00 | 16,984.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Dupont Jakob | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Not found | A | Common Stock | 38741 | $0.00 | 38,741.0000 | 39,904,603 | 9999.99% | 0.10% |
| Sept. 22, 2023 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Director | A | Stock Option (Right to Buy) | 392461 | $0.00 | 392,461.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Director | A | Stock Option (Right to buy) | 5879 | $0.00 | 5,879.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Director | A | Stock Option (Right to buy) | 3534 | $0.00 | 3,534.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2023 | Pyxis Oncology, Inc. | $PYXS | Dupont Jakob | Director | A | Stock Option (Right to buy) | 17250 | $0.00 | 17,250.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Dupont Jakob | EVP, Head of R&D | S | Common Stock | 5074 | $3.63 | 290,794.0000 | 0 | 1.71% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Dupont Jakob | EVP, Head of R&D | A | Common Stock | 141328 | $0.00 | 295,868.0000 | 0 | 91.45% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Dupont Jakob | EVP, Head of R&D | A | Employee Stock Option (Right to Buy) | 317987 | $0.00 | 317,987.0000 | 0 | 9999.99% | 0.00% |